Drug: VELCADE Injury: Peripheral swelling Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
118927055 | VELCADE | Peripheral swelling | TAKEDA | 67.00 YR | F | 94 KG | 20160810 | GB |
119525234 | VELCADE | Peripheral swelling | TEVA | 67.00 YR | F | 94 KG | 20160902 | GB |
119808454 | VELCADE | Peripheral swelling | BAUSCH AND LOMB | 67.00 YR | F | 94 KG | 20160901 | GB |
121407765 | VELCADE | Peripheral swelling | BAUSCH AND LOMB | 67.00 YR | F | 93 KG | 20160725 | GB |
121655645 | VELCADE | Peripheral swelling | WATSON | 67.00 YR | F | 93 KG | 20160801 | GB |
125182584 | VELCADE | Peripheral swelling | CONCORDIA | 67.00 YR | F | 94 KG | 20160906 | GB |
125420621 | VELCADE | Peripheral swelling | TAKEDA | 0.00 | F | 0 | 20160708 | US |
127521391 | VELCADE | Peripheral swelling | FDA-CTU | 74.52 YR | M | 88 KG | 20160915 | US |
Total Records: 8 Number of Pages: 1